Buscar
Mostrando ítems 21-30 de 592
Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells
(2014)
Human adipose‐derived mesenchymal stromal cells (AMSCs) grown in platelet lysate are promising agents for therapeutic tissue regeneration. Here, we investigated whether manipulation of epigenetic events by the clinically ...
Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
(BioMed Central, 2017)
Background: The liver has the remarkable capacity to regenerate in order to compensate for lost or damaged
hepatic tissue. However, pre-existing pathological abnormalities, such as hepatic steatosis (HS), inhibits the ...
Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
(BioMed Central, 2017)
Background: The liver has the remarkable capacity to regenerate in order to compensate for lost or damaged
hepatic tissue. However, pre-existing pathological abnormalities, such as hepatic steatosis (HS), inhibits the ...
MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy
(2012)
complication is diabetic nephropathy (DN), a clinical syndrome associated with kidney damage and an increased risk of cardiovascular disease. Irrespective of the type of diabetes, DN follows a well-known temporal course. ...
MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy
(2012)
complication is diabetic nephropathy (DN), a clinical syndrome associated with kidney damage and an increased risk of cardiovascular disease. Irrespective of the type of diabetes, DN follows a well-known temporal course. ...
A novel bimodal approach for treating atrophic bone non-unions with extracorporeal shockwaves and autologous mesenchymal stem cell transplant
(Churchill Livingstone, 2018)
© 2017 Elsevier LtdWe propose a novel approach for the treatment of atrophic bone non-unions via parallel applications of extracorporeal shock wave therapy (ESWT) and an autologous mesenchymal stem cell transplant. The ...
A novel bimodal approach for treating atrophic bone non unions with extracorporeal shockwaves and autologous mesenchymal stem cell transplant
(Elsevier, 2018)
We propose a novel approach for the treatment of atrophic bone non-unions via parallel applications of extracorporeal shock wave therapy (ESWT) and an autologous mesenchymal stem cell transplant. The hypothesis resides on ...
Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?
(2015)
Multipotent mesenchymal stromal cells [also referred to as mesenchymal stem cells (MSCs)] are a heterogeneous subset of stromal cells. They can be isolated from bone marrow and many other types of tissue. MSCs are currently ...